After approval of gadopentetate dimeglumine by the US Food and Drug Administration (FDA) in 1988, the use of GBCAs has multiplied, aiding lesion depiction and therapeutic guidance in over 500 million ...

603678.SS Fujian Torch Electron Technology Co., Ltd.

Contrast enhanced exams were performed using either gadobenate dimeglumine (Bracco Diagnostics) or gadobutrol (Bayer AG), both at 0.1 mmol/kg. ASL was performed using pseudocontinuous labeling with a ...

Nausea, unpleasant taste, or headache may occur. If any of these effects last or get worse, tell your health care professional. Remember that this medication has been prescribed because your ...